Login / Signup
Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease - Reply.
Haruki Kobayashi
Published in:
Respirology (Carlton, Vic.) (2020)
Keyphrases
</>
interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis